Product/Composition:- | Bendamustine Hydrochloride |
---|---|
Strength:- | 25 mg/vial, 100 mg/vial |
Form:- | Injection (powder for solution) |
Reference Brands:- | Treanda®, Bendeka®(US), Levact®(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Bendamustine Hydrochloride is a chemotherapy drug used in the treatment of CLL and NHL, available as 25 mg and 100 mg IV infusions in the US and EU.
Bendamustine Hydrochloride Injection, available in 25 mg and 100 mg vials, is a widely used oncology API and formulation for the treatment of chronic lymphocytic leukemia (CLL) and non-Hodgkin lymphoma (NHL). Marketed under brands like Treanda®, Bendeka®, and Levact® in the US and EU, it offers dual mechanisms of action—alkylation and antimetabolite activity—leading to potent cancer cell apoptosis. Ideal for pharmaceutical B2B sourcing, Bendamustine is supplied as a sterile powder or solution for IV infusion, suitable for hospitals and oncology treatment centers across regulated markets. GMP-certified manufacturing ensures quality compliance for international partnerships.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications